multiple-sclerosis

Documents about multiple-sclerosis

• Cognitive behavioural therapy in multiple sclerosis: A randomized controlled pilot study of acceptance and commitment therapy.#625752Lund University Publications
• Bilateral Anodal Cerebellar tDCS for Multidomain Dysfunctions in Patients With Multiple Sclerosis#843373ClinicalTrials.gov
• Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS#913824ClinicalTrials.gov
• Abuse in individuals with multiple sclerosis: the SocialMS Italian study#625043IRIS
• Multiple sclerosis as an asynchronous neuroinflammatory system.#368194NCBI PubMed Central
• Meta-Analysis: Suicidality in Patients with Multiple Sclerosis#432368Zenodo (CERN)
• The Interplay of Neighborhood Deprivation, Race, and Multiple Sclerosis.#480795NCBI PubMed Central
• Comparison Study of PF530 and Betaferon in Healthy Subjects#830905ClinicalTrials.gov
• International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: Opportunities and Challenges#253597Europe PMC
• Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND Study#273336Europe PMC
• A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)#855955ClinicalTrials.gov
• Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve)#859326ClinicalTrials.gov
• Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial#876675ClinicalTrials.gov
• Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Severe Gait Impairment: A Feasibility Study#883947ClinicalTrials.gov
• Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial#896368ClinicalTrials.gov
• A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab#898484ClinicalTrials.gov
• Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations#902518ClinicalTrials.gov
• A Real-world Study Comparing the Effectiveness of Ofatumumab and Ocrelizumab Treatment in Multiple Sclerosis Patients#915891ClinicalTrials.gov
• Vitamin D receptor genetic polymorphisms and the risk of multiple sclerosis: A systematic review and meta-analysis#948034Repositorio de Universidad Autónoma de Chile.
• Eficacia del ejercicio físico aeróbico sobre la fatiga en personas con esclerosis múltiple#273712Gestión del Repositorio Documental de la Universidad de Salamanca
• Cognition and socio-professional attainment in paediatric-onset Multiple Sclerosis: a 12-year reappraisal#823159IRIS
• This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.#873630ClinicalTrials.gov
• Viral associations in multiple sclerosis: pathogenetic mechanisms and therapeutic implications.#221148NCBI PubMed Central
• Presence and Impact of Fatigue in Patients With Multiple Sclerosis.#362097NCBI PubMed Central
• Targeting progressive multiple sclerosis: Toward mechanism-informed precision medicine.#425139NCBI PubMed Central
• Data-Driven Fatigue Trajectories in Multiple Sclerosis and Their Predictors.#469312NCBI PubMed Central
• Single-Dose Study of a New Formulation of BIIB061#806066ClinicalTrials.gov
• Effectiveness of Hippotherapy Simulator in PwMS#829282ClinicalTrials.gov
• Waking Hypnosis in the Treatment of MS-related Fatigue#847700ClinicalTrials.gov
• The Impact of Parasitic Infection on Multiple Sclerosis and Nephrotic Syndrome#849222ClinicalTrials.gov
• Exercise-Induced Irisin and Brain Changes#851106ClinicalTrials.gov
• Intestinal Immunity in Neurologic Disease#866385ClinicalTrials.gov
• COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS#882009ClinicalTrials.gov
• Safety of Exposure to Natalizumab During Pregnancy#887987ClinicalTrials.gov
• Exploring Pathology Related to Slowly Expanding Lesions Using Advanced Imaging#898463ClinicalTrials.gov
• The SEMS Project: Staying Employed With MS#899166ClinicalTrials.gov
• ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.#903124ClinicalTrials.gov
• Identifying multiple sclerosis in women of childbearing age in six European countries: a contribution from the ConcePTION project#173006HAL (France)
• 38 U.S.C. § 7330 — Multiple sclerosis centers of excellence#587934US Code (LII)
• Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis#863503ClinicalTrials.gov
• Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) Risk#625045IRIS
• Performance of the 2024 McDonald Criteria in Patients Under Evaluation for Suspected Multiple Sclerosis#677866IRIS
• Methods of estimating prevalence of multiple sclerosis in six European healthcare data sources: a contribution from the ConcePTION project#178057HAL (France)
• Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion (Journal of Neurology, (2022), 269, 10, (5382-5394), 10.1007/s00415-022-11193-w)#254343IRIS
• Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya#833861ClinicalTrials.gov
• Assessing the Effects of Ongoing Ocrelizumab (OCR) Therapy on Fatigue and Cognition in Veterans With Multiple Sclerosis#849206ClinicalTrials.gov
• AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis#845203ClinicalTrials.gov
• Disparities in imaging and management of multiple sclerosis: a review.#4452NCBI PubMed Central
• Normative Modelling of Brain Volume in Multiple Sclerosis#161680Unpaywall
• Trajectories of processing speed in multiple sclerosis across disease-modifying therapies.#218790NCBI PubMed Central